Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Post by Greencashon Jul 08, 2019 10:01am
49 Views
Post# 29895196

CannTrust down 15% premarket on negative regulatory audit

CannTrust down 15% premarket on negative regulatory audit

CannTrust down 15% premarket on negative regulatory audit

CannTrust Holdings (NYSE:CTST) is down 15% premarket on modest volume in response to a recent audit of its Pelham, Ontario greenhouse facility by Health Canada showing non-compliance with certain regulations.

Specifically, the company was growing cannabis in five unlicensed rooms during the period from October 2018 to March 2019 while its applications were under review (licenses were issued in April 2019). Company employees also provided inaccurate information to the regulator.

Health Canada has placed a hold on ~5,200 kg of dried cannabis that was harvested from the (then) unlicensed rooms until it confirms that the weed is compliant with regulations.

CannTrust has also voluntarily held ~7,500 kg of pot harvested at its Vaughan facility that was produced in previously unlicensed rooms until it can be verified as compliant.

Operations at both sites remain fully licensed at this point.

The company says that the holds may result in temporary product shortages for some customers, adding that it does not know, at this point, if the situation will affect financial results.

CEO Peter Aceto says, "Our team has focused on building a culture of transparency, trust and excellence in every aspect of our business, including our interactions with the regulator. We have made many changes to make this right with Health Canada. We made errors in judgement, but the lessons we have learned here will serve us well moving forward."


Bullboard Posts